A Mendelian randomization study demonstrated that lipoprotein lipase (LPL) genetic variants associated to low TG levels have the same association with ASCVD risk as LDL receptor variants determining a reduction in plasma LDL-C. This evidence concerns the gene LPL and atherosclerosis.